Skip to main content
ScholarsBetaWeill Cornell Medicine

Publications

17 publications

Funding

3 grants

Active

1 grant
  • KP
    UBR5's Mechanisms of Action in Tumorigenesis and Immunoregulation
    National Cancer Institute · 2023–2028
    R01CA273716-01A1
Completed grants (2)
  • KP
    Investigation of UBR5 and its signaling as a novel target for breast cancer therapy
    U.S. Department of Defense · 2021–2025
    W81XWH-21-1-0261
  • KP
    UBR5, E3 Ubiquitin Ligase, in Triple Negative Breast Cancers: Potential Role in Anti-Tumor Immunity and Cancer Metabo
    Qatar National Research Fund · 2020–2024 · via Weill Cornell Medical College/Qatar
    NPRP-S 12-0317-190379